Bristol Myers Squibb: An Undervalued Dividend Stock With Growth Potential
Drew Angerer/Getty Images News
For a while now, pharmaceutical stocks have been trading at a discount to the broader market. Over the course of the past 12-months, the Vanguard Health Care ETF (VHT) has returned 23% compared to the S&P 500 returning ~35%…
